Clinical Research Institute of Michigan – Shores Rheumatology
Primary Coordinator: Amelia Paliewicz 586-598-3329 X 201
- Indication: Rheumatoid Arthritis
- Enrollment Status: Closed
- Protocol: GS-US-417-0304
- Drug: Filgotinib
- Sponsor: Gilead
- Description: A Multicenter, Open-Label, Long-Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Subjects with Rheumatoid Arthritis
